Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30004255HIVENSG00000177189.14protein_codingRPS6KA3NoNo6197B4DG22
B7ZB17
P51812
TVIS30016750HIVENSG00000177189.14protein_codingRPS6KA3NoNo6197B4DG22
B7ZB17
P51812
TVIS30009905HIVENSG00000177189.14protein_codingRPS6KA3NoNo6197B4DG22
B7ZB17
P51812
TVIS30004256HIVENSG00000177189.14protein_codingRPS6KA3NoNo6197B4DG22
B7ZB17
P51812
TVIS30005020HIVENSG00000177189.14protein_codingRPS6KA3NoNo6197B4DG22
B7ZB17
P51812
TVIS30017141HIVENSG00000177189.14protein_codingRPS6KA3NoNo6197B4DG22
B7ZB17
P51812
TVIS30019625HIVENSG00000177189.14protein_codingRPS6KA3NoNo6197B4DG22
B7ZB17
P51812
TVIS30019628HIVENSG00000177189.14protein_codingRPS6KA3NoNo6197B4DG22
B7ZB17
P51812
TVIS30072849HIVENSG00000177189.14protein_codingRPS6KA3NoNo6197B4DG22
B7ZB17
P51812
TVIS30072850HIVENSG00000177189.14protein_codingRPS6KA3NoNo6197B4DG22
B7ZB17
P51812
TCGA Plot Options
Drug Information
GeneRPS6KA3
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0004876
UniProt IDP51812
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830